Call for Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast Cancer

Last update: Oct 6, 2026

Details

Location: Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Mexico, South Korea, Spain, Taiwan, UK, USA
Funding Agency: Other
Contracting Authority: Pfizer (USA)
Contracting Authority Type: Supplier / manufacturer
Status: Open
Budget: USD 8,000,000
Award ceiling: N/A
Award floor: N/A
Sector: Health, Research & Innovation
Eligible applicants: Unrestricted / Unspecified
Eligible nationalities: Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Mexico, South Korea, Spain, Taiwan, UK, USA
Date posted: Oct 6, 2026
Share

Similar grants

By Locations
There are no similar grants by locations
By Sectors
Funding Agency: Government
Status: open
Location: Norway
Funding Agency: NPO
Status: open
Location: Worldwide